Biogen Idec Inc (NASDAQ:BIIB) and AbbVie (NYSE:ABBV) announced positive top-line results from the Phase 3 DECIDE clinical trial, designed to evaluate the superiority of once-monthly, subcutaneous daclizumab high-yield process (DAC HYP) when compared to intramuscular interferon beta-1a (IFN -1a), as a potential treatment for relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS). Results showed that DAC HYP was superior on the study’s primary endpoint, demonstrating a statistically significant 45 percent reduction in annualized relapse rate (ARR) compared to IFN -1a (p<0.0001). Biogen Idec Inc (NASDAQ:BIIB) net profit margin is 25.00% and weekly performance is -3.38%. On last trading day company shares ended up $304.79. Analysts mean target price for the company is $348.64. Biogen Idec Inc (NASDAQ:BIIB) distance from 50-day simple moving average (SMA50) is 2.28%.
The Dow Chemical Company (NYSE:DOW) reported $0.79 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.71 by $0.08. The company had revenue of $14.50 billion for the quarter, compared to the consensus estimate of $14.72 billion. During the same quarter last year, the company posted $0.69 earnings per share. The Dow Chemical Company’s revenue was up .5% compared to the same quarter last year. On average, analysts predict that The Dow Chemical Company will post $2.97 earnings per share for the current fiscal year. The Dow Chemical Company (NYSE:DOW) shares fell -0.57% in last trading session and ended the day on $52.00. DOW Gross Margin is 16.70% and its return on assets is 6.90%. The Dow Chemical Company (NYSE:DOW) quarterly performance is 5.48%.
Royal Dutch Shell plc (ADR) (NYSE:RDS.A) announced that it purchased for cancellation 450,000 “A” Shares at a price of 2375.63 pence per share. Royal Dutch Shell plc (ADR) (NYSE:RDS.A) shares moved down -0.40% in last trading session and was closed at $80.45, while trading in range of $80.17 – $80.50.
On 16 JUNE Syngenta AG (ADR) (NYSE:SYT) announced an agreement to acquire the German and Polish winter wheat and winter oilseed rape (WOSR) breeding and business operations of Lantmannen, the Swedish food, energy and agriculture group. Syngenta AG (ADR) (NYSE:SYT) ended the last trading day at $74.57. Company weekly volatility is calculated as 0.64% and price to cash ratio as 38.64. Syngenta AG (ADR) (NYSE:SYT) showed a negative weekly performance of -2.19%.
Novozymes A/S (OTCMKTS: NVZMF) on last trading day company shares ended up $49.02.